The gut microbiome: an under-recognised contributor to the COVID-19 pandemic?
Open Access
- 1 January 2020
- journal article
- review article
- Published by SAGE Publications in Therapeutic Advances in Gastroenterology
Abstract
It has been noted that certain baseline gut profiles of COVID-19 patients are associated with a more severe disease course, and the gut microbiome impacts the disease course of several contributory risk factors to the severity of COVID-19. A protein called ACE-2, which is found in the small intestine among other sites, is a key receptor for COVID-19 virus entry; there is evidence that the gut microbiome influences ACE-2 receptor expression, and hence may play a role in influencing COVID-19 infectivity and disease severity. Furthermore, the gut microbiome plays a significant role in immune regulation, and hence may be pivotal in influencing the immune response to COVID-19. In terms of understanding COVID-19 treatments, the gut microbiome is known to interact with several drug classes being used to target COVID-19 and should be factored into our understanding of how patients respond to treatment. Importantly, our understanding of the role of the gut microbiome in COVID-19 infection remains in its infancy, but future research may potentially aid our mechanistic understanding of viral infection, and new ways in which we might approach treating it.Keywords
This publication has 112 references indexed in Scilit:
- Probiotic yogurt improves antioxidant status in type 2 diabetic patientsNutrition, 2012
- Modulation of the immune system by UV radiation: more than just the effects of vitamin D?Nature Reviews Immunology, 2011
- Probiotic Prophylaxis of Ventilator-associated PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Composition, variability, and temporal stability of the intestinal microbiota of the elderlyProceedings of the National Academy of Sciences of the United States of America, 2010
- Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic AdultsPLOS ONE, 2010
- The NLRP3 Inflammasome Mediates In Vivo Innate Immunity to Influenza A Virus through Recognition of Viral RNAImmunity, 2009
- Inflammasome recognition of influenza virus is essential for adaptive immune responsesThe Journal of Experimental Medicine, 2009
- Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patientsProceedings of the National Academy of Sciences of the United States of America, 2008
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004
- Vitamin D Receptor As an Intestinal Bile Acid SensorScience, 2002